Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions
Dr. Laura Michaelis interviews Dr. Taylor Brooks about his Blood Journal paper on bispecific antibodies, epcoritamab and glofitamab, for aggressive B-cell lymphoma. The discussion covers real-world data from 245 patients with relapsed or refractory DLBCL, suggesting a potential…